Calumet (CLMT) H.C. Wainwright Renewables Fuels Virtual Day presentation summary
Event summary combining transcript, slides, and related documents.
H.C. Wainwright Renewables Fuels Virtual Day presentation summary
25 Mar, 2026Key investment highlights
Two distinct, cash-generating platforms: Specialties and Renewables, both with competitive advantages.
Specialties business has shown robust performance and resilience through market cycles.
Montana Renewables delivers positive Adjusted EBITDA and is expanding SAF production, with much of the new capacity pre-sold at a premium.
Accelerated deleveraging with $220 million debt reduction in 2025 and $80 million annual debt service savings after a federal loan.
Specialties business performance
Historical mid-cycle Adjusted EBITDA averages $286 million, with recent years outperforming this average.
Achieved record production levels and $100 million in cost reductions, including $61 million in opex savings.
Specialty margins remain strong, outpacing historic levels despite a softer macro environment.
Diversified customer base and agile supply chain support margin resilience.
Montana Renewables growth and outlook
Renewable fuels production at 12,000 bpd, increasing to 13,000 bpd in Q2 2026.
SAF production expanding from 30 million to 120–150 million gallons per year with MaxSAF® 150 project.
Over 100 million gallons of SAF pre-sold at a $1–2/gallon premium to renewable diesel.
Facility benefits from geographic advantages, low-cost feedstock access, and short supply chains.
Latest events from Calumet
- Adjusted EBITDA rose 30%, net loss narrowed, and $222M debt was cut amid record specialty output.CLMT
Q4 202527 Feb 2026 - Q2 2024 delivered $66.8M EBITDA, record volumes, and C-Corp conversion amid margin pressure.CLMT
Q2 20241 Feb 2026 - Record SAF output, $1.44B DOE loan, and $150M sale-leaseback drive growth and liquidity.CLMT
Q3 202415 Jan 2026 - DOE loan enables major SAF expansion, debt reduction, and strategic growth for renewables.CLMT
Status Update10 Jan 2026 - Unitholders to vote on conversion to a corporation, exchanging units for shares and warrants.CLMT
Proxy Filing2 Dec 2025 - C-Corp conversion, DOE loan, and asset sale drive deleveraging and renewables growth.CLMT
Q4 20241 Dec 2025 - Q2 2025 posted a $147.9M loss, but cost cuts and specialty gains drove operational progress.CLMT
Q2 202523 Nov 2025 - Q1 2025 net loss deepened, but EBITDA, liquidity, and SAF expansion advanced.CLMT
Q1 202520 Nov 2025 - Q3 2025 saw record EBITDA, net income, and SAF progress, with cost cuts and deleveraging.CLMT
Q3 202513 Nov 2025